| Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019) P Bhatia, V Sharma, O Alam, A Manaithiya, P Alam, MT Alam, M Imran European Journal of Medicinal Chemistry 204, 112640, 2020 | 95 | 2020 |
| Recent advancement in drug design and discovery of pyrazole biomolecules as cancer and inflammation therapeutics MJ Alam, O Alam, MJ Naim, F Nawaz, A Manaithiya, M Imran, HK Thabet, ... Molecules 27 (24), 8708, 2022 | 42 | 2022 |
| GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus A Manaithiya, O Alam, V Sharma, MJ Naim, S Mittal, IA Khan Bioorganic Chemistry 113, 104998, 2021 | 32 | 2021 |
| Insight into structure activity relationship of DPP-4 inhibitors for development of antidiabetic agents V Mathur, O Alam, N Siddiqui, M Jha, A Manaithiya, S Bawa, N Sharma, ... Molecules 28 (15), 5860, 2023 | 27 | 2023 |
| Recent developments made in the assessment of the antidiabetic potential of gymnema species-From 2016 to 2020 O Alam, S Naaz, V Sharma, A Manaithiya, J Khan, A Alam Journal of ethnopharmacology 286, 114908, 2022 | 26 | 2022 |
| Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis J Firdaus, N Siddiqui, O Alam, A Manaithiya, K Chandra Archiv der Pharmazie 356 (5), 2200421, 2023 | 14 | 2023 |
| Current status of novel pyridine fused derivatives as anticancer agents: An insight into future perspectives and structure activity relationship (SAR) A Manaithiya, O Alam, V Sharma, MJ Naim, S Mittal, F Azam, A Husain, ... Current Topics in Medicinal Chemistry 21 (25), 2292-2349, 2021 | 14 | 2021 |
| Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking M Jha, O Alam, MJ Naim, V Sharma, P Bhatia, AA Sheikh, F Nawaz, ... European Journal of Pharmaceutical Sciences 153, 105494, 2020 | 12 | 2020 |
| Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based … R Bhowmik, R Kant, A Manaithiya, D Saluja, B Vyas, R Nath, KA Qureshi, ... Frontiers in Pharmacology 14, 1265573, 2023 | 11 | 2023 |
| Identification of potential inhibitor against Ebola virus VP35: insight into virtual screening, pharmacoinformatics profiling, and molecular dynamic studies R Bhowmik, A Manaithiya, B Vyas, R Nath, S Rehman, S Roy, R Roy Structural Chemistry 33 (3), 815-831, 2022 | 6 | 2022 |
| Elucidating molecular mechanism and chemical space of chalcones through biological networks and machine learning approaches A Manaithiya, R Bhowmik, S Acharjee, S Sharma, S Kumar, M Imran, ... Computational and structural biotechnology journal 23, 2811-2836, 2024 | 2 | 2024 |
| Identification of novel pyrazole containing ɑ-glucosidase inhibitors: insight into pharmacophore, 3D-QSAR, virtual screening, and molecular dynamics study J Firdaus, N Siddiqui, O Alam, A Manaithiya, K Chandra Journal of Biomolecular Structure and Dynamics 41 (19), 9398-9423, 2023 | 2 | 2023 |
| An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV and SARS-CoV-2 3CLpro A Manaithiya, O Alam, S Mittal, MJ Naim, M Imran, AS Alshrari, AA Sheikh, ... Mini Reviews in Medicinal Chemistry 23 (5), 576-632, 2023 | 2 | 2023 |
| A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors A Manaithiya, R Bhowmik, K Bhattacharya, R Ray, SS Shyamal, F Carta, ... Frontiers in Pharmacology 15, 1457012, 2024 | 1 | 2024 |
| Integrating virtual screening, pharmacoinformatics profiling, and molecular dynamics: identification of promising inhibitors targeting 3CLpro of SARS-CoV-2 A Mohammad, A Zheoat, A Oraibi, A Manaithiya, K S. Almaary, ... Frontiers in Molecular Biosciences 10, 1306179, 2024 | 1 | 2024 |
| Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism S Giovannuzzi, SS Shyamal, R Bhowmik, R Ray, A Manaithiya, F Carta, ... Computers in Biology and Medicine 181, 109029, 2024 | | 2024 |
| Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based … R Bhowmik, R Kant, A Manaithiya, D Saluja, B Vyas, R Nath, KA Qureshi, ... FRONTIERS IN PHARMACOLOGY 14, 2024 | | 2024 |
| A multi-dimensional systems biology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors A Manaithiya, R Bhowmik, K Bhattacharya, R Ray, SS Shyamal, F Carta, ... chemrxiv, 0-0, 2024 | | 2024 |
| A data and knowledge-driven integrated modeling approach to organ-specific Tuberculosis subtype discovery: A one health paradigm R Ray, R Bhowmik, SS Shyamal, A Manaithiya, F Carta, CT Supuran, ... chemrxiv, 0-0, 2024 | | 2024 |
| Identification of novel pyrazole containing-glucosidase inhibitors: insight into pharmacophore, 3D-QSAR, virtual screening, and molecular dynamics study N Siddiqui, O Alam, A Manaithiya, K Chandra Journal of Biomolecular Structure and Dynamics 41 (19), 9398-9423, 2023 | | 2023 |
Prof. (Dr.) Ozair Alam, Awarded Youn...Professor, School of Pharmaceutical Education and Research (NIRF # 1 Rank in Pharmacy)Email được xác minh tại jamiahamdard.ac.in